The cash injection will also allow Corxel to start phase 2 testing in type 2 diabetes and help to fund a phase 3 programme in obesity, with some also earmarked for two other programmes – an ...

AbbVie extended the patent life on Humira for years, enough time to more than replace the sales. Now Merck and Bristol Myers ...

Selecting winning stocks in early 2026 requires looking beyond short-term noise, as U.S. equities respond to easing inflation ...

CEO Rob Michael highlighted AbbVie's strong Q4 2024 performance, which exceeded initial guidance with $56.3 billion in total ...

The investment bank said many companies faced thesis-changing Phase 3 readouts this year, with outcomes that could materially reshape valuations regardless of the broader macro backdrop. But UBS also ...

Not sure if that brilliant article was penned by a human or AI? Here are some simple ways to tell. Rachel is a freelancer based in Echo Park, Los Angeles and has been writing and producing content for ...